Administration of both, TDCA and valine in DIO mice, caused a robust and sustained weight loss, reduced fat tissue, and reversed DIO-associated T2D based on a decreased food intake mediated through suppression of the hypothalamic orexigenic peptide melanin-concentrating hormone (MCH) intake. Here, PMCH is linked to type 2 diabetes mellitus.